These BRAF mutations constitutively activate BRAF and its downstream signaling of the Mitogen-Activated Protein -kinase pathway promoting proliferation, survival and spreading of tumor cells [10], [11], [12], [13]. The gene discussed is BRAF; the disease is neoplasm.